78 FR 122 pgs. 38099-38100 - Notice of Intent To Grant An Exclusive License
Type: NOTICEVolume: 78Number: 122Pages: 38099 - 38100
FR document: [FR Doc. 2013-15107 Filed 6-24-13; 8:45 am]
Agency: Veterans Affairs Department
Official PDF Version: PDF Version
DEPARTMENT OF VETERANS AFFAIRS
Notice of Intent To Grant An Exclusive License
AGENCY:
Office of Research and Development, Department of Veterans Affairs.
ACTION:
Notice of intent.
SUMMARY:
Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development (ORD), intends to grant to Somahlution, Inc., a Delaware corporation, doing business at 3401 Fiechtner Drive, Fargo, North Dakota 58103, USA, an exclusive license to practice the following patent: U.S. Patent No. 6,569,615, "Composition and Methods for Tissue Preservation," issued May 27, 2003. Copies of the published patent may be obtained from the U.S. Patent and Trademark Office at www.uspto.gov.
DATES:
Comments must be received within 15 days from the date of this published Notice.
ADDRESSES:
Written comments may be submitted through www.regulations.gov; by mail or hand-delivery to the Director, Regulations Management (02REG), Department of Veterans Affairs, 810 Vermont Avenue NW., Room 1068, Washington, DC 20420; or by fax to (202) 273-9026. Copies of comments received will be available for public inspection in the Office of Regulation Policy and Management, Room 1063B, between the hours of 8:00 a.m. and 4:30 p.m., Monday through Friday (except holidays). Call (202) 461-4902 for an appointment. (This is not a toll-free number.) In addition, during the comment period, comments may be viewed online through the Federal Docket Management System (FDMS) at http://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Director of Technology Transfer Program, Office of Research and Development (10P9TT), Department of Veterans Affairs, 810 Vermont Avenue NW., Washington, DC 20420, (202) 443-5640. (This is not a toll-free number.)
SUPPLEMENTARY INFORMATION:
It is in the public interest to so license these inventions to Somahlution, Inc. in order to facilitate the development and commercialization of new and useful means for "in situ" and "ex vivo" preservation of tissues and organs. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted, unless VA ORD receives written evidence and argument within 15 days from the date of this published Notice, which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.
Approved: June 11, 2013.
Jose D. Riojas,
Interim Chief of Staff, Department of Veterans Affairs.
[FR Doc. 2013-15107 Filed 6-24-13; 8:45 am]
BILLING CODE P